These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 37733208

  • 1. Persistent NRG1 Type III Overexpression in Spinal Motor Neurons Has No Therapeutic Effect on ALS-Related Pathology in SOD1G93A Mice.
    Hernández S, Salvany S, Casanovas A, Piedrafita L, Soto-Bernardini MC, Tarabal O, Blasco A, Gras S, Gatius A, Schwab MH, Calderó J, Esquerda JE.
    Neurotherapeutics; 2023 Oct; 20(6):1820-1834. PubMed ID: 37733208
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic Role of Neuregulin 1 Type III in SOD1-Linked Amyotrophic Lateral Sclerosis.
    Mòdol-Caballero G, García-Lareu B, Verdés S, Ariza L, Sánchez-Brualla I, Brocard F, Bosch A, Navarro X, Herrando-Grabulosa M.
    Neurotherapeutics; 2020 Jul; 17(3):1048-1060. PubMed ID: 31965551
    [Abstract] [Full Text] [Related]

  • 3. Gene therapy for overexpressing Neuregulin 1 type I in skeletal muscles promotes functional improvement in the SOD1G93A ALS mice.
    Mòdol-Caballero G, Herrando-Grabulosa M, García-Lareu B, Solanes N, Verdés S, Osta R, Francos-Quijorna I, López-Vales R, Calvo AC, Bosch A, Navarro X.
    Neurobiol Dis; 2020 Apr; 137():104793. PubMed ID: 32032731
    [Abstract] [Full Text] [Related]

  • 4. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
    Lasiene J, Komine O, Fujimori-Tonou N, Powers B, Endo F, Watanabe S, Shijie J, Ravits J, Horner P, Misawa H, Yamanaka K.
    Acta Neuropathol Commun; 2016 Feb 18; 4():15. PubMed ID: 26891847
    [Abstract] [Full Text] [Related]

  • 5. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M, Giribaldi F, Melone M, Bonifacino T, Musante I, Carminati E, Rossi PI, Vergani L, Voci A, Conti F, Puliti A, Bonanno G.
    Neurobiol Dis; 2014 Apr 18; 64():48-59. PubMed ID: 24361555
    [Abstract] [Full Text] [Related]

  • 6. Nuclear Localization of Human SOD1 in Motor Neurons in Mouse Model and Patient Amyotrophic Lateral Sclerosis: Possible Links to Cholinergic Phenotype, NADPH Oxidase, Oxidative Stress, and DNA Damage.
    Martin LJ, Koh SJ, Price A, Park D, Kim BW.
    Int J Mol Sci; 2024 Aug 22; 25(16):. PubMed ID: 39201793
    [Abstract] [Full Text] [Related]

  • 7. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1G93A ) mouse model of amyotrophic lateral sclerosis include sex-dependent phenotypes.
    Kreilaus F, Guerra S, Masanetz R, Menne V, Yerbury J, Karl T.
    Genes Brain Behav; 2020 Feb 22; 19(2):e12604. PubMed ID: 31412164
    [Abstract] [Full Text] [Related]

  • 8. Interfering with lysophosphatidic acid receptor edg2/lpa1 signalling slows down disease progression in SOD1-G93A transgenic mice.
    Gento-Caro Á, Vilches-Herrando E, García-Morales V, Portillo F, Rodríguez-Bey G, González-Forero D, Moreno-López B.
    Neuropathol Appl Neurobiol; 2021 Dec 22; 47(7):1004-1018. PubMed ID: 33508894
    [Abstract] [Full Text] [Related]

  • 9. AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice.
    Chen HH, Yeo HT, Huang YH, Tsai LK, Lai HJ, Tsao YP, Chen SL.
    Skelet Muscle; 2024 Jul 24; 14(1):17. PubMed ID: 39044305
    [Abstract] [Full Text] [Related]

  • 10. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Bonifacino T, Cattaneo L, Gallia E, Puliti A, Melone M, Provenzano F, Bossi S, Musante I, Usai C, Conti F, Bonanno G, Milanese M.
    Neuropharmacology; 2017 Sep 01; 123():433-445. PubMed ID: 28645622
    [Abstract] [Full Text] [Related]

  • 11. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Lu Y, Tang C, Zhu L, Li J, Liang H, Zhang J, Xu R.
    Int J Biol Sci; 2016 Sep 01; 12(9):1140-9. PubMed ID: 27570488
    [Abstract] [Full Text] [Related]

  • 12. Accumulation of misfolded SOD1 outlines distinct patterns of motor neuron pathology and death during disease progression in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Salvany S, Casanovas A, Piedrafita L, Gras S, Calderó J, Esquerda JE.
    Brain Pathol; 2022 Nov 01; 32(6):e13078. PubMed ID: 35584812
    [Abstract] [Full Text] [Related]

  • 13. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.
    Turner BJ, Ackerley S, Davies KE, Talbot K.
    Hum Mol Genet; 2010 Mar 01; 19(5):815-24. PubMed ID: 20008901
    [Abstract] [Full Text] [Related]

  • 14. Comparing effects of microgravity and amyotrophic lateral sclerosis in the mouse ventral lumbar spinal cord.
    Yoshikawa M, Ishikawa C, Li H, Kudo T, Shiba D, Shirakawa M, Muratani M, Takahashi S, Aizawa S, Shiga T.
    Mol Cell Neurosci; 2022 Jul 01; 121():103745. PubMed ID: 35660087
    [Abstract] [Full Text] [Related]

  • 15. Cdk5 inhibition in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis suppresses neurodegeneration and extends survival.
    Kim A, Lee DY, Sung JJ.
    J Neurochem; 2024 Sep 01; 168(9):2908-2925. PubMed ID: 38934222
    [Abstract] [Full Text] [Related]

  • 16. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Ringer C, Büning LS, Schäfer MK, Eiden LE, Weihe E, Schütz B.
    Neurobiol Dis; 2013 Jun 01; 54():32-42. PubMed ID: 23466699
    [Abstract] [Full Text] [Related]

  • 17. Early deficits in GABA inhibition parallels an increase in L-type Ca2+ currents in the jaw motor neurons of SOD1G93A mouse model for ALS.
    Venugopal S, Ghulam-Jhelani Z, Ahn IS, Yang X, Wiedau M, Simmons D, Chandler SH.
    Neurobiol Dis; 2023 Feb 01; 177():105992. PubMed ID: 36623607
    [Abstract] [Full Text] [Related]

  • 18. Targeting autotaxin impacts disease advance in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Gento-Caro Á, Vilches-Herrando E, Portillo F, González-Forero D, Moreno-López B.
    Brain Pathol; 2022 May 01; 32(3):e13022. PubMed ID: 34585475
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
    Tokuda E, Okawa E, Watanabe S, Ono S.
    Hum Mol Genet; 2014 Mar 01; 23(5):1271-85. PubMed ID: 24163136
    [Abstract] [Full Text] [Related]

  • 20. SOD1G93A Astrocyte-Derived Extracellular Vesicles Induce Motor Neuron Death by a miRNA-155-5p-Mediated Mechanism.
    Marton S, Miquel E, Acosta-Rodríguez J, Fontenla S, Libisch G, Cassina P.
    ASN Neuro; 2023 Mar 01; 15():17590914231197527. PubMed ID: 37644868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.